1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Nigeria Pharmaceuticals and Healthcare Report Q2 2016

Nigeria Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 91 pages

Includes 3 FREE quarterly updates

BMI View: Nigeria's prospects of attaining national health coverage will largely depend upon the successof the National Health Act. This, however, will continue to face a number of challenges that have previouslyled to delays in its implementation. The eventual rollout of the act will make Nigeria an attractive prospectfor multinational drugmakers over the long-term, though political and fiscal barriers limit the successfullikelihood of its implementation and subsequent investment opportunities.

Headline Expenditure Projections

- Pharmaceuticals: NGN175.90bn (USD891mn) in 2015 to NGN187.33bn (USD905mn) in 2016; +6.5%in local currency terms and +1.6% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: NGN3.97trn (USD20.08bn) in 2015 to NGN4.43trn (USD21.41bn) in 2016; +11.7% inlocal currency terms and +6.6% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Nigeria Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Nigeria 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Nigeria 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Nigeria 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Nigeria 2014-2020) 30
Industry Risk Reward Index 31
Middle East and Africa Risk/Reward Index - Q2 2016 31
Nigeria Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 42
Pricing Regime 44
Reimbursement Regime 44
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Nigeria 2010-2015) 46
Table: Healthcare Personnel (Nigeria 2010-2015) 47
Table: Healthcare Activity (Nigeria 2010-2015) 47
Research and Development 54
Clinical Trials 54
Epidemiology 56
Competitive Landscape 58
Research-Based Industry 58
Table: Multinational Market Activity 62
Pharmaceutical Distribution and Retail Sector 63
Company Profile 66
GlaxoSmithKline 66
Fidson Healthcare 69
May and Baker 72
Merck and Co 75
Neimeth Pharmaceuticals 77
Demographic Forecast 80
Demographic Outlook 80
Table: Population Headline Indicators (Nigeria 1990-2025) 81
Table: Key Population Ratios (Nigeria 1990-2025) 81
Table: Urban/Rural Population and Life Expectancy (Nigeria 1990-2025) 82
Table: Population By Age Group (Nigeria 1990-2025) 82
Table: Population By Age Group % (Nigeria 1990-2025) 83
Glossary 85
Methodology 87
Pharmaceutical Expenditure Forecast Model 87
Healthcare Expenditure Forecast Model 87
Notes On Methodology 88
Risk/Reward Index Methodology 89
Index Overview 90
Table: Pharmaceutical Risk/Reward Index Indicators 90
Indicator Weightings 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


Download Unlimited Documents from Trusted Public Sources

Pharmaceutical Markets in China

  • November 2016
    23 pages
  • Pharmaceutical  

    Hospital  

  • China  

View report >

Therapy Market in Europe

  • November 2016
    19 pages
  • Therapy  

  • Europe  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Related Market Segments :

Pharmaceutical
Healthcare

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.